Equities

Shanghai Fudan Forward S&T Co Ltd

600624:SHH

Shanghai Fudan Forward S&T Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)3.20
  • Today's Change-0.05 / -1.54%
  • Shares traded12.82m
  • 1 Year change-46.31%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments304308252
Total Receivables, Net110119130
Total Inventory637656665
Prepaid expenses131116
Other current assets, total1.180.9058
Total current assets1,0651,0941,120
Property, plant & equipment, net429471496
Goodwill, net------
Intangibles, net757275
Long term investments206209215
Note receivable - long term------
Other long term assets------
Total assets1,7971,8671,916
LIABILITIES
Accounts payable526069
Accrued expenses141922
Notes payable/short-term debt563515511
Current portion long-term debt/capital leases1111511
Other current liabilities, total4556113
Total current liabilities785664725
Total long term debt2614250
Total debt699672572
Deferred income tax4.336.670.05
Minority interest4111183
Other liabilities, total137140142
Total liabilities9921,0641,000
SHAREHOLDERS EQUITY
Common stock685685685
Additional paid-in capital172172172
Retained earnings (accumulated deficit)171193
Treasury stock - common(35)(35)(8.42)
Unrealized gain (loss)(6.93)(6.93)--
Other equity, total(27)(22)(25)
Total equity805804916
Total liabilities & shareholders' equity1,7971,8671,916
Total common shares outstanding679679684
Treasury shares - common primary issue5.375.371.20
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.